10401-18-0

Basic information

• Product Name: 2-broMo-3-Methoxybenzaldehyde
• Synonyms: 2-broMo-3-Methoxybenzaldehyde
• CAS NO: 10401-18-0
• Molecular Formula: C₈H₇BrO₂
• Molecular Weight: 215.04398
• Mol File: 10401-18-0.mol
• Article Data: 10

Chemical Properties

• Melting Point: 69.5-70 °C(Solv: benzene (71-43-2); ligroine (8032-32-4))
• Boiling Point: 277.6±20.0 °C(Predicted)
• Appearance: /
• Density: 1.522±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 2-broMo-3-Methoxybenzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 2-broMo-3-Methoxybenzaldehyde(10401-18-0)
• EPA Substance Registry System: 2-broMo-3-Methoxybenzaldehyde(10401-18-0)

Safety Data

• Hazardous Substances Data: 10401-18-0(Hazardous Substances Data)

Usage

General Description

2-bromo-3-methoxybenzaldehyde is a chemical compound with the molecular formula C8H7BrO2. It is an organic compound that is commonly used in the synthesis of pharmaceuticals and organic materials. It is a pale yellow solid with a strong, sweet, and floral odor. The compound is often used as a building block in the creation of various pharmaceutical and agrochemical products. It is also used in the production of organic materials and as an intermediate in the synthesis of other chemicals. 2-broMo-3-Methoxybenzaldehyde is an important tool in the field of organic chemistry and is widely used in research and manufacturing processes.

Upstream product

• 196081-71-7 2-bromo-3-hydroxy-benzaldehyde 
• 199436-55-0 (2-bromo-3-methoxyphenyl)methanol 
• 591-31-1 3-methoxy-benzaldehyde 
• 38197-43-2 2-bromo-3-methylanisole 
• 74-88-4 methyl iodide 

Downstream Products

• 88377-29-1 2-bromo-3-methoxybenzoic acid 
• 1232407-19-0 1-(2-bromo-3-methoxyphenyl)ethanone 
• 71887-29-1 methyl 2-(2,5-dimethoxy-4-methylbenzyl)-3-methoxybenzoate 

Relevant articles and documents

Structure Guided Design, Synthesis, and Biological Evaluation of Novel Benzosuberene Analogues as Inhibitors of Tubulin Polymerization

A promising design paradigm for small-molecule inhibitors of tubulin polymerization that bind to the colchicine site draws structural inspiration from the natural products colchicine and combretastatin A-4 (CA4). Our previous studies with benzocycloalkeny

Synthesis and structure–activity relationships of aristoyagonine derivatives as brd4 bromodomain inhibitors with x-ray co-crystal research

Epigenetic regulation is known to play a key role in progression of anti-cancer therapeutics. Lysine acetylation is an important mechanism in controlling gene expression. There has been increasing interest in bromodomain owing to its ability to modulate t

BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS

This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy and/or epileptic seizure disorders.